Ubiquitin-dependent recruitment of SLFN11 to chromatin is regulated by deubiquitinase (DUB) and RNF168.

Saved in:
Bibliographic Details
Title: Ubiquitin-dependent recruitment of SLFN11 to chromatin is regulated by deubiquitinase (DUB) and RNF168.
Authors: Taniyama D; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA., Pegoraro G; High-Throughput Imaging Facility (HiTIF), Laboratory of Receptor Biology and Gene Expression, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA., Wu Y; Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA., Huang SN; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA., Thomas CJ; Division of Preclinical Innovation, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA., Ozbun L; High-Throughput Imaging Facility (HiTIF), Laboratory of Receptor Biology and Gene Expression, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA., Tran AD; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA., Saha LK; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA., Murai J; Department of Cell Growth and Tumor Regulation, Proteo-Science Center, Premier Institute for Advanced Studies, Ehime University, Toon, Ehime 791-0295, Japan., Jo U; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA.; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA., Pommier Y; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA.
Source: Research square [Res Sq] 2026 Apr 10. Date of Electronic Publication: 2026 Apr 10.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet ISSN: 2693-5015 (Electronic) Linking ISSN: 26935015 NLM ISO Abbreviation: Res Sq Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2693-5015
DOI:10.21203/rs.3.rs-9297013/v1